 | • レポートコード：TPM-B04125 • 出版社/出版日：Transparency Market Research / 2017年12月 • レポート形態：英文、PDF、189ページ • 納品方法：Eメール • 産業分類：製薬・医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、抗菌薬の世界市場について調べ、抗菌薬の世界規模、市場動向、市場環境、薬剤分類別分析、投与経路別分析、流通経路別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、バリューチェーン分析、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・抗菌薬の世界市場動向 ・抗菌薬の世界市場環境 ・抗菌薬のバリューチェーン分析 ・抗菌薬の世界市場規模 ・抗菌薬の世界市場規模：薬剤分類別 ・抗菌薬の世界市場規模：投与経路別 ・抗菌薬の世界市場規模：流通経路別 ・抗菌薬の世界市場：地域別市場規模・分析 ・抗菌薬の北米市場規模・予測 ・抗菌薬のアメリカ市場規模・予測 ・抗菌薬の中南米市場規模・予測 ・抗菌薬のヨーロッパ市場規模・予測 ・抗菌薬のアジア市場規模・予測 ・抗菌薬の中東市場規模・予測 ・抗菌薬のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Antibacterial Drugs Market: Overview
This report provides in-depth region wise and country wise analysis of the antibacterial drugs market. Stakeholders of this report include manufacturers of antibacterial drugs, raw material suppliers, researchers and new players planning to enter the market.
The report provides qualitative and quantitative analysis of the global antibacterial drugs market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes market share held by companies, market size, and forecast for the global antibacterial drugs market in major countries globally such as the U.S., Canada, Germany, France, United Kingdom, Japan, China,, India, Brazil, Mexico, South Africa GCC countries and others. Market revenue is provided in terms of US$ Mn from 2015 to 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 for all the segments, considering 2016 as the base year. The executive summary of the report provides a snapshot of the antibacterial drugs with information on leading segments, country wise market information with respect to the market size, growth rate (CAGR %), and growth factors.
Global Antibacterial Drugs Market: Scope of the Study
The market overview section comprises impact factors such as drivers, restraints, and opportunities for the global antibacterial drugs market. These factors would aid the stakeholders in establishing a strong foothold in the global antibacterial drugs market. Furthermore, the market overview section comprises key industry events, product overview, market attractiveness analysis and emerging trend in the antibacterial drugs. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market.
Global Antibacterial Drugs Market: Key Segments
Based on drug class, the global antibacterial drugs market is classified into B – lactams, quinolones, macrolides, tetracycline, aminoglycoside, sulfonamide, phenicols, and others. In terms of routes of administration, the global antibacterial drugs market has been segmented into enteral, parenteral and others. Likewise, the global antibacterial drugs market has been further segmented into hospital pharmacies, drug stores and retail pharmacies and online sales, in terms of distribution channel. The retail stores and drug stores segment is anticipated to experience the largest market share in 2016 and this segment will grow by a significant rate during the forecast period.
Global Antibacterial Drugs Market: Regional Outlook
Geographically, the antibacterial drugs market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, U.K., France, Japan, China, India, Brazil, Mexico, and South Africa and others have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the antibacterial drugs market in various regions has been provided in this section.
Global Antibacterial Drugs Market: Competitive Outlook
This report also includes various ups and downs about particular country or geography that has impacted the overall market globally. The report provides a detailed outline/blueprint of the antibacterial drugs market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market. The report concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players. Prominent key players are Bayer AG, Pfizer Inc., Sanofi, GlaxoSmithKline Plc. (GSK), Merck & Co., Inc., AstraZeneca, Johnson and Johnson, Bristol Myers Squibb Company, Novartis AG, and Allergen plc
Global antibacterial drugs market is segmented as given below:
Global Antibacterial Drugs Market, by Drug Class
B – lactams
Quinolones
Macrolides
Tetracycline
Aminoglycoside
Sulfonamide
Phenicols
Others
Global Antibacterial Drugs Market, by Routes of Administration
Enteral,
Parenteral
Others
Global Antibacterial Drugs Market, by Distribution Channel
Hospital Pharmacies
Drug Stores and Retail Pharmacies
Online Sales
Global Antibacterial Drugs Market, by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Rest of Europe
Asia Pacific (APAC)
China
Japan
India
Rest of APAC
Latin America (LATAM)
Brazil
Mexico
Rest of LATAM
Middle East & Africa (MEA)
GCC
South Africa
Rest of Middle East & Africa
Chapter 1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Assumptions and Acronyms Used
Chapter 2. Research Methodology
Chapter 3. Executive Summary
Chapter 4. Market Overview
4.1. Product Overview
4.2. Key Industry Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
4.3.4. Porter’s Five Forces Representation
4.3.5. Antibacterial Drugs Market- Value Chain Analysis & Supply-Demand Scenario
4.3.6. Antibacterial Drugs Market Outlook
4.3.7. Anti-Bacterial Drugs Pipeline Analysis
Chapter 5. Global Antibacterial Drugs Market Analysis, by Drug Class, 2015 – 2025
5.1. Key Findings
5.2. Definition
5.3. Introduction
5.4. Global Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
5.5. Global Antibacterial Drugs Market Analysis, by Drug Class
5.5.1. β-lactam
5.5.2. Quinolones
5.5.3. Macrolides
5.5.4. Tetracycline
5.5.5. Aminoglycoside
5.5.6. Sulfonamide
5.5.7. Phenicols
5.5.8. Others
5.6. Global Antibacterial Drugs Market Attractiveness Analysis, by Drug Class
5.7. Global Antibacterial Drugs Market Forecast, by Drug Class
5.8. Key Trends
Chapter 6. Global Antibacterial Drugs Market Analysis, by Routes of Administration
6.1. Key Findings
6.2. Definitions
6.3. Introduction
6.4. Global Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
6.5. Global Antibacterial Drugs Market Analysis, by Routes of Administration
6.5.1. Enteral
6.5.2. Parenteral
6.5.3. Others
6.6. Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration
6.7. Global Antibacterial Drugs Market Forecast, by Routes of Administration
Chapter 7. Global Antibacterial Drugs Market Analysis, by Channels of Distribution
7.1. Key Findings
7.2. Definitions
7.3. Introduction
7.4. Global Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
7.5. Global Antibacterial Drugs Market Analysis, by Channels of Distribution
7.5.1. Hospital Pharmacies
7.5.2. Drug Stores & Retail Pharmacies
7.5.3. Online Sales
7.6. Global Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution
7.7. Global Antibacterial Drugs Market Forecast, by Channels of Distribution
7.8. Key Trends
Chapter 8. Global Antibacterial Drugs Market Analysis, by Region
8.1. Key Findings
8.2. Introduction
8.3. Global Antibacterial Drugs Market Value Share Analysis, by Region, 2016 and 2025
8.4. Global Antibacterial Drugs Market Attractiveness Analysis, by Region, 2016
8.5. Global Antibacterial Drugs Market Forecast, by Region, 2015–2025
Chapter 9. North America Antibacterial Drugs Market Analysis
9.1. North America Antibacterial Drugs Market Overview
9.2. North America Antibacterial Drugs Market Forecast, Country wise, 2015–2025
9.3. North America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
9.4. North America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
9.5. North America Antibacterial Drugs Market Forecast, by Drug Class, 2015–2025
9.6. North America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
9.7. North America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
9.8. North America Antibacterial Drugs Market Forecast, by Routes of Administration, 2015–2025
9.9. North America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
9.10. North America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
9.11. North America Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015–2025
9.12. Key Trends
Chapter 10. Europe Antibacterial Drugs Market Analysis
10.1. Europe Antibacterial Drugs Market Overview
10.2. Europe Antibacterial Drugs Market Forecast, Country wise, 2015–2025
10.3. Europe Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
10.4. Europe Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
10.5. Europe Antibacterial Drugs Market Forecast, by Drug Class, 2015–2025
10.6. Europe Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
10.7. Europe Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
10.8. Europe Antibacterial Drugs Market Forecast, by Routes of Administration, 2015–2025
10.9. Europe Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
10.10. Europe Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
10.11. Europe Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015–2025
10.12. Key Trends
Chapter 11. Asia Pacific Antibacterial Drugs Market Analysis
11.1. Asia Pacific Antibacterial Drugs Market Overview
11.2. Asia Pacific Antibacterial Drugs Market Forecast, Country wise, 2015–2025
11.3. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
11.4. Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
11.5. Asia Pacific Antibacterial Drugs Market Forecast, by Drug Class, 2015–2025
11.6. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
11.7. Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
11.8. Asia Pacific Antibacterial Drugs Market Forecast, by Routes of Administration, 2015–2025
11.9. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
11.10. Pacific Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
11.11. Asia Pacific Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015–2025
11.12. Key Trends
Chapter 12. Latin America Antibacterial Drugs Market Analysis
12.1. Latin America Antibacterial Drugs Market Overview
12.2. Latin America Antibacterial Drugs Market Forecast, Country wise, 2015–2025
12.3. Latin America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
12.4. Latin America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
12.5. Latin America Antibacterial Drugs Market Forecast, by Drug Class, 2015–2025
12.6. Latin America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
12.7. Latin America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
12.8. Latin America Antibacterial Drugs Market Forecast, by Routes of Administration, 2015–2025
12.9. Latin America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
12.10. Latin America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
12.11. Latin America Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015–2025
12.12. Key Trends
Chapter 13. Middle East & Africa Antibacterial Drugs Market Analysis
13.1. Middle East & Africa Antibacterial Drugs Market Overview
13.2. Middle East & Africa Antibacterial Drugs Market Forecast, Country wise, 2015–2025
13.3. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
13.4. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
13.5. Middle East & Africa Antibacterial Drugs Market Forecast, by Drug Class, 2015–2025
13.6. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
13.7. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
13.8. Middle East & Africa Antibacterial Drugs Market Forecast, by Routes of Administration, 2015–2025
13.9. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
13.10. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
13.11. Middle East & Africa Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015–2025
13.12. Key Trends
Chapter 14. Competition Landscape
14.1. Leading Antibacterial Drugs Sales Analysis, 2014 – 2016
14.2. Competition Matrix
14.3. Company Profiles
14.3.1. Bayer AG
14.3.1.1. Company Description
14.3.1.2. Business Overview
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Pfizer Inc.
14.3.2.1. Company Description
14.3.2.2. Business Overview
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Sanofi
14.3.3.1. Company Description
14.3.3.2. Business Overview
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. GlaxoSmithKline plc
14.3.4.1. Company Description
14.3.4.2. Business Overview
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Merck & Co., Inc
14.3.5.1. Company Description
14.3.5.2. Business Overview
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. AstraZeneca
14.3.6.1. Company Description
14.3.6.2. Business Overview
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. Johnson and Johnson
14.3.7.1. Company Description
14.3.7.2. Business Overview
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. Bristol-Myers Squibb Company
14.3.8.1. Company Description
14.3.8.2. Business Overview
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. Novartis AG
14.3.9.1. Company Description
14.3.9.2. Business Overview
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. Allergen Plc.
14.3.10.1. Company Description
14.3.10.2. Business Overview
14.3.10.3. SWOT Analysis
14.3.10.4. Strategic Overview
Table 01: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 02: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015–2025
Table 03: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015–2025
Table 04: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, Country Wise, 2015–2025
Table 06: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 07: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015–2025
Table 08: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distributions, 2015–2025
Table 09: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, Country Wise, 2015–2025
Table 10: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 11: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015–2025
Table 12: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015–2025
Table 13: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, Country Wise, 2015–2025
Table 14: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 15: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015–2025
Table 16: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015–2025
Table 17: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Country Wise, 2015–2025
Table 18: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 19: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015–2025
Table 20: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015–2025
Table 21: Middle East & Africa Antibacterial Drugs Market Size (US$ Mn) Forecast, by Country Wise, 2015–2025
Table 22: Middle East & Africa Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 23: MEA Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015–2025
Table 24: MEA Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015–2025